We believe that medically-important information about our clinical research should be available to the public, including importantly the healthcare professionals, people with cancer and their loved ones who might benefit most from our research.
Takeda is committed to transparency and integrity in its clinical research, in alignment with our Core Values and in compliance with all relevant laws and regulations related to the registration and disclosure of our sponsored clinical study information. This means we are dedicated to the timely registration of clinical studies, communication of clinical study result summaries and publication of our company-sponsored clinical research.
In addition, Takeda supports the pharmaceutical industry's initiatives related to increased clinical study transparency, including the principles and positions of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), the Japan Pharmaceutical Manufacturers Association (JPMA), the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of America (PhRMA) relative to the disclosure and publication of results from clinical studies for approved medicines.
Takeda is committed to complying with the PhRMA/EFPIA and BIO Principles for Responsible Clinical Trial Data Sharing and providing anonymous, individual patient-level data with qualified researchers for legitimate purposes, while also safeguarding the privacy of our research participants.
Takeda accepts research requests from qualified researchers for patient-level clinical trial data using the Takeda link on the www.ClinicalStudyDataRequest.com data sharing portal.